NCT00331552
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +8 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
HER2-positive Breast Cancer
Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
202 public trials
83 recruiting studies
HER2-positive Breast Cancer trial results
NCT00791037
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +8 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01245205
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
- Locations
-
- Sanford Cancer Center-Oncology Clinic Sioux Falls, South Dakota, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT00077376
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +8 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
NCT00006228
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +8 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
NCT00098605
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +16 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00003440
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +8 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
Active, Not Recruiting
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
NCT03975647
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- University of South Alabama Health Children's and Women's Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- University of South Alabama Health University Hospital Mobile, Alabama, United States
- Banner Gateway Medical Center Gilbert, Arizona, United States
Active, Not Recruiting
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
NCT06316531
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China